The newly approved prefilled syringe for self-injection of Vyvgart Hytrulo will provide more convenience and flexibility for ...

That means the future of Roivant is tied to the success, or otherwise, of Immunovant’s attempts to break into the FcRn market ...

Immunovant, Inc. (IMVT) announced on Monday that Roivant President Eric Venker will succeed Pete Salzmann as the new CEO, ...

The FDA has approved a subcutaneous self-injectable for adults with generalized myasthenia gravis who are anti-acetylcholine ...

Across the recent three months, 11 analysts have shared their insights on argenx ARGX + Free Alerts , expressing a variety of ...

Roivant Sciences is making serious changes to subsidiary Immunovant, announcing Monday a series of C-suite changes and new disease targets.

The U.S. Food and Drug Administration has approved a self-injection version of Vyvgart Hytrulo (efgartigimod alfa and ...

antibody positive and adult patients with chronic inflammatory demyelinating polyneuropathy (CIDP). Vyvgart Hytrulo prefilled ...

The US Food and Drug Administration (FDA) has approved a pre-filled syringe version of argenx’s Vyvgart, giving generalised ...

KORU Medical Systems, Inc.’s KRMD share price has surged by 5.80%, which has investors questioning if this is right time to ...

After proper training on subcutaneous injection technique, the prefilled syringe may be administered by the patient or caregiver.

News and commentary from the world of neurology and neuroscience ...